We are live on ! Find out more
CASI

CASI Pharmaceuticals
CASI

Delisted

CASI was delisted on the 25th of February, 2026.

Back to rankings

30 hedge funds and large institutions have $1.92M invested in CASI Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

3% less funds holding

Funds holding: 31 → 30 (-1)

26% less capital invested

Capital invested by funds: $2.59M → $1.92M (-$670K)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

Holders
30
Holders Change
-1
Holders Change %
-3.23%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$22.4K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$19.7K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$15.3K
4
Renaissance Technologies
Renaissance Technologies
New York
+$5.67K
5
BFA
BlackRock Fund Advisors
California
+$3.67K

Top Sellers

1
SM
Sabby Management
Florida
-$217K
2
WSCM
Wellington Shields Capital Management
New York
-$141K
3
CWM
Concert Wealth Management
California
-$45K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$25.4K
5
MC
Moors & Cabot
Massachusetts
-$20.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
26
Citigroup
New York
– -$12K -1,150 Closed
IA
27
IFP Advisors
Florida
– +$34 +3 New
Morgan Stanley
28
Morgan Stanley
New York
– +$68 +6 +22%
Bank of Montreal
29
Bank of Montreal
Ontario, Canada
– +$102 +9 New
1
2